Cordlife Group Valuation

Is P8A undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of P8A when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate P8A's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate P8A's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for P8A?

Key metric: As P8A is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for P8A. This is calculated by dividing P8A's market cap by their current revenue.
What is P8A's PS Ratio?
PS Ratio1.1x
SalesS$36.61m
Market CapS$39.73m

Price to Sales Ratio vs Peers

How does P8A's PS Ratio compare to its peers?

The above table shows the PS ratio for P8A vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.3x
1B1 HC Surgical Specialists
2.2xn/aS$41.5m
OTX Medinex
2.1xn/aS$27.2m
1D4 Aoxin Q & M Dental Group
0.7xn/aS$23.0m
MIJ Alliance Healthcare Group
0.4xn/aS$26.6m
P8A Cordlife Group
1.1xn/aS$39.7m

Price-To-Sales vs Peers: P8A is good value based on its Price-To-Sales Ratio (1.1x) compared to the peer average (1.3x).


Price to Sales Ratio vs Industry

How does P8A's PS Ratio compare vs other companies in the SG Healthcare Industry?

1 CompanyPrice / SalesEstimated GrowthMarket Cap
1H3 Clearbridge Health
0.2xn/aUS$1.38m
No more companies available in this PS range
P8A 1.1xIndustry Avg. 1.5xNo. of Companies3PS012345+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: P8A is good value based on its Price-To-Sales Ratio (1.1x) compared to the SG Healthcare industry average (1.5x).


Price to Sales Ratio vs Fair Ratio

What is P8A's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

P8A PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.1x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate P8A's Price-To-Sales Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies